EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY-NC 3.0

Applications of ZIF-8-Based Nanoplatforms in Orthopedic Diseases: Evidence Base, Mechanistic Attribution, and Translational Barriers

Tong Wu, Yan Wang, Xiaotian Feng, Benchao Dong, Peichuan Yang, Mengran Qin, Xiuguo Ge, Yimin Wang, JianXiong Ma iD

International Journal of Nanomedicine · 2026

DOI: 10.2147/ijn.s646799 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift International Journal of Nanomedicine, 2026. Verfasst von Tong Wu und 8 weiteren Autor:innen. Beteiligte Einrichtung: Tianjin Key Laboratory of Agricultural Animal Breeding and Healthy Husbandry, College of Animal Science and Veterinary Medicine, Tianjin Agricultural…. Hauptthemen laut MEDLINE: Imidazoles, Zeolites, Bone Diseases. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Orthopedic diseases severely impair the quality of life of hundreds of millions of people worldwide and impose a substantial socioeconomic burden. Conventional treatments remain limited in terms of disease-site targeting, sustained drug release, and mitigation of adverse effects. Zeolitic imidazolate framework-8 (ZIF-8), formed through the coordination of Zn2⁺ with 2-methylimidazole, has a porous structure, a high cargo-encapsulation capacity, and environment-dependent disassembly characteristics. Through the release of Zn2⁺, it may also contribute to osteogenesis, antibacterial activity, and microenvironmental modulation. Accordingly, ZIF-8 has been investigated in preclinical studies of osteosarcoma, osteoporosis, osteoarthritis, osteomyelitis, and bone defect repair. Using a structured narrative and critical approach, this review summarizes strategies for ZIF-8 preparation, drug loading, and functionalization and compares the evidence across orthopedic indications with respect to research stage, validation of stimulus responsiveness, mechanistic attribution, biosafety, and barriers to clinical translation. Current evidence is derived primarily from in vitro and small-animal studies, and no therapeutic studies in humans have been identified. Although many studies have reported pH-dependent release in vitro, few have directly measured framework disassembly, cargo release, or Zn2⁺ exposure within disease sites in vivo. In multicomponent systems, the individual contributions of the therapeutic cargo, ZIF-8 framework, Zn2⁺, and surface modifications have rarely been adequately distinguished. Data on long-term toxicity, biodistribution, and clearance also remain limited, and batch-to-batch consistency and large-scale production have not been systematically validated. Future studies should prioritize formulation-specific physicochemical characterization and the establishment of safe dose windows. They should also include component controls that distinguish the contributions of the cargo, framework, and Zn2⁺, as well as clinically relevant comparators and large-animal models. These measures are needed to determine the incremental value and translational feasibility of ZIF-8 platforms for specific orthopedic indications.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ImidazolesZeolitesBone DiseasesHumansAnimalsZincTranslational Research, BiomedicalMetal-Organic Frameworks

Stichwörter der Autor:innen

ZIF-8biosafetyclinical translationmetal–organic frameworksorthopedic diseases

Substanzen

ZIF-8 metal-organic frameworkImidazolesZeolitesZinc2-methylimidazoleMetal-Organic Frameworks

Autor:innen und Institutionen

  • Tianjin Key Laboratory of Agricultural Animal Breeding and Healthy Husbandry, College of Animal Science and Veterinary Medicine, Tianjin Agricultural University, Tianjin, 300392, People's Republic of China.
  • Tianjin Hospital, Tianjin University, Tianjin, People's Republic of China.
  • Tianjin Orthopedic Institute, Tianjin, People's Republic of China.

ORCID-Profile: JianXiong Ma

Zitieren

APA

Wu, T., Wang, Y., Feng, X., Dong, B., Yang, P., Qin, M., Ge, X., Wang, Y., & Ma, J. (2026). Applications of ZIF-8-Based Nanoplatforms in Orthopedic Diseases: Evidence Base, Mechanistic Attribution, and Translational Barriers. International Journal of Nanomedicine. https://doi.org/10.2147/ijn.s646799

Vancouver

Wu T, Wang Y, Feng X, Dong B, Yang P, Qin M, et al. Applications of ZIF-8-Based Nanoplatforms in Orthopedic Diseases: Evidence Base, Mechanistic Attribution, and Translational Barriers. International Journal of Nanomedicine. 2026. doi:10.2147/ijn.s646799

BibTeX
@article{Wu2026,
  author = {Wu, Tong and Wang, Yan and Feng, Xiaotian and Dong, Benchao and Yang, Peichuan and Qin, Mengran and Ge, Xiuguo and Wang, Yimin and Ma, JianXiong},
  title = {Applications of ZIF-8-Based Nanoplatforms in Orthopedic Diseases: Evidence Base, Mechanistic Attribution, and Translational Barriers},
  journal = {International Journal of Nanomedicine},
  year = {2026},
  doi = {10.2147/ijn.s646799}
}
Kostenlos starten →